(FDUS) Fidus Investment - Ratings and Ratios

Fidus Investment Corporation is a business development company that specializes in providing financing solutions to lower middle-market companies in the United States. Its investment strategy focuses on leveraged buyouts, refinancings, and strategic acquisitions, with a preference for companies in industries such as aerospace and defense, business services, and healthcare products and services.

The companys investment approach is characterized by its avoidance of turnarounds and distressed situations, instead targeting companies with stable cash flows and growth potential. Fidus typically invests between $5 million and $15 million per transaction in companies with annual revenues between $10 million and $150 million and EBITDA between $3 million and $20 million.

In addition to debt investments, Fidus also seeks to acquire minority equity stakes and board observation rights in its portfolio companies, allowing it to exert some control over the companies it invests in. This approach enables Fidus to balance its risk appetite with potential returns, while also providing its portfolio companies with access to capital and strategic guidance.

Analyzing the companys , we can see that the stock price is currently at $19.93, with a 20-day SMA of $19.78 and a 50-day SMA of $19.06. The ATR indicates a relatively low volatility of 1.87%. Considering the , the companys market cap is approximately $714.94M, with a P/E ratio of 8.80 and a forward P/E of 9.68. The RoE is 11.58%, indicating a relatively healthy return on equity.

Based on the and , our forecast suggests that Fidus Investment Corporation is likely to experience a moderate increase in stock price in the near term, driven by its stable financial performance and favorable industry trends. The companys diversified investment portfolio and cautious approach to investing are likely to continue to attract investors seeking stable returns. As the stock price is currently above its 50-day SMA, we expect it to continue its upward trend, potentially reaching $21.50 in the next quarter.